Marotta MG, Mapulanga T, Maina M, Daly J, Camero M. Development and Qualification of a Pseudotyped Virus-Based Microneutralisation Assay for Influenza D Virus. Influenza Other Respir Viruses. 2026 Apr;20(4):e70
Background: Epidemiological surveillance of influenza D virus (IDV) has gained increased priority following recent serological findings indicating its potential zoonosis in humans. In this context, it is crucial to develop strong, reproducible, reliable and scalable immunological assays that can be quickly implemented in the surveillance of new emerging threats. Serology is a powerful tool for immune monitoring prior to infection and conducting epidemiological surveillance. However, the traditional microneutralisation (MN) assay requires wild-type viruses, considerably limiting its accessibility for some laboratories. Pseudotyped viruses (PVs) allow for expanded usage since they are safer and more flexible for adaptation to specific strains and enable application in laboratories without implementation in high biosecurity containment.
Methods: In this study, we conducted the qualification of a PV-based MN (pMN) assay with IDV-PVs that express the HEF glycoprotein of the D/Swine/Italy/199724-3/2015 strain. The assay functionality was examined using 14 bovine serum samples, assessing key analytical parameters including accuracy, specificity, precision, linearity and robustness.
Results: The findings demonstrate the IDV pMN assay to be an effective method for the detection of neutralising antibodies.
Conclusions: Therefore, the assay can be a valuable tool to facilitate large-scale surveillance and provide data to inform immunisation strategy development.
Methods: In this study, we conducted the qualification of a PV-based MN (pMN) assay with IDV-PVs that express the HEF glycoprotein of the D/Swine/Italy/199724-3/2015 strain. The assay functionality was examined using 14 bovine serum samples, assessing key analytical parameters including accuracy, specificity, precision, linearity and robustness.
Results: The findings demonstrate the IDV pMN assay to be an effective method for the detection of neutralising antibodies.
Conclusions: Therefore, the assay can be a valuable tool to facilitate large-scale surveillance and provide data to inform immunisation strategy development.
See Also:
Latest articles in those days:
- Inactivation of Pseudomonas Enveloped Bacteriophage Phi6 (H5N1 Surrogate) in Raw Bovine Milk using a Combination of Ultraviolet light (254 nm), Advanced Oxidative Process and Endogenous Lactoperoxidas 10 hours ago
- Convergent Evolution of the N156 K Mutation in A(H1N1)pdm09 Hemagglutinin Contributes to Antigenic Drift and Cluster Transition 1 days ago
- Influenza Vaccine Technology Transfer: A Mixed-Methods Study with Vaccine Manufacturers and Global Experts to Assess Successes, Challenges, and Opportunities 1 days ago
- Research Progress on Avian Influenza Virus and Autophagy: A Review 1 days ago
- From Global Insights to Local Action: Bridging Vaccine Design and Manufacturing Gaps in H5N1 Pandemic Readiness 1 days ago
[Go Top] [Close Window]


